ArticleFrontiers in veterinary science2025
Non-contrast enhanced visualization of the equine foot vasculature in a cadaver model using time-of-flight sequence.
Article in Frontiers in veterinary science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Cyclooxygenase-2 and von Willebrand factor-an immunohistochemical study of the equine foot with and without laminitis, post-mortem perfused with paraffin oil.Frontiers in veterinary science · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The objective of this study was to establish a non-contrast enhanced MR angiography (NC-MRA) sequence for the equine foot (EF) using a post-mortem angiography model. Materials and methods: Time-of-flight (TOF) sequences were tested using variable parameter settings and 3 slice orientations during vascular perfusion of frozen-thawed cadaver EF with paraffine oil. Transverse and dorsal orientations were planned perpendicular or parallel to the sublamellar vascular plexus at the dorsal aspect of P3, or approximately perpendicular to the coronary plexus. Visibility of the coronary plexus, sublamellar plexus, palmar plexus, terminal arch and its respective branches, solar plexus, and the marginal circumflex vessels was evaluated in a total of 74 sequences. Results: Twelve EF of 10 horses were scanned. Visibility of vessels as small as the sublamellar plexus was best achieved by 3D-TOF sequences in transverse and dorsal orientations with the following parameters: pixel size 0.34 × 0.48 mm, slice thickness 0.2 mm, interslice gap 0.2 mm, TR/TE 21.2/4.7 ms, flip angle 16°, TONE ramp 70%, acquisition time 22.05 min. Only for the sublamellar plexus, the transverse acquisition showed a slightly better visualization than the dorsal acquisition, however the latter could include nearly the entire EF in the field of view with the same acquisition time. Conclusion and discussion: 3D-TOF allowed visualization down to at least the sublamellar venous plexus which is reported to have diameters of approximately 0.45 mm. The post-mortem model facilitated establishment of a TOF sequence without the need for experimental animals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.